Sentence: Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with everolimus ( RAD001 ) and alemtuzumab : a Phase I/II study .
Drug combination annotation:
[{'class': 'NEG', 'spans': ['everolimus', 'alemtuzumab'], 'is_context_needed': True}]